Search results for "cortico"

showing 10 items of 693 documents

Pituitary-adrenal responses to ovine corticotropin-releasing factor in polycystic ovary syndrome and in other hyperandrogenic patients.

1990

This study was carried out to further characterize the pituitary-adrenal androgen responses of hyperandrogenic patients with 'classic' polycystic ovary syndrome (PCO) and others who were less distinctive and have been called 'PCO-like'. PCO-like patients differed from PCO only in that serum luteinizing hormone (LH) levels were normal and anovulation was not consistent. Ovine corticotropin-releasing factor (CRF) resulted in normal responses of adrenocorticotropic hormone and cortisol in the two groups when compared to controls, while androstenedione (delta 4A) and dehydroepiandrosterone (DHEA) responses were significantly elevated. There were no differences in the responses of PCO and PCO-li…

Adultendocrine systemmedicine.medical_specialtyHirsutismAdolescentmedicine.drug_classCorticotropin-Releasing HormoneEndocrinology Diabetes and MetabolismDehydroepiandrosteronePituitary-Adrenal SystemAdrenocorticotropic hormoneAnovulationBasal (phylogenetics)EndocrinologyAdrenocorticotropic HormoneInternal medicinemedicineHumansAndrostenedionebusiness.industryAndrostenedioneObstetrics and GynecologyDehydroepiandrosteroneLuteinizing HormoneAndrogenmedicine.diseasePolycystic ovaryeye diseasesHormonesEndocrinologyOvine corticotropin-releasing factorFemalebusinesshuman activitieshormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologyAnovulationPolycystic Ovary SyndromeGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
researchProduct

Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome

1995

Objective To reevaluate the clinical significance of elevations of adrenal androgens in polycystic ovary syndrome (PCOS). Methods Thirty women with PCOS and ten ovulatory controls were evaluated. Serum dehydroepiandrosterone (DHEA) sulfate and 11β-hydroxyandrostenedione were measured before and after 3 and 6 months of GnRH agonist (GnRH-A) therapy. All controls and 15 women with PCOS received intravenous ACTH before and after GnRH-A therapy. Results Twenty-one (70%) of the women with PCOS had elevations of DHEA sulfate, and 16 (53%) had elevations in 11/3-hydroxyandrostenedione. Only two women with PCOS had normal values of both adrenal androgens. After GnRH-A therapy, only 11 subjects (37%…

Adultendocrine systemmedicine.medical_specialtyendocrine system diseasesmedicine.drug_classDehydroepiandrosteroneOvaryPeptide hormonechemistry.chemical_compoundDehydroepiandrosterone sulfateAdrenocorticotropic HormoneInternal medicinepolycyclic compoundsmedicineHumansAndrostenedioneTriptorelin PamoateDehydroepiandrosterone Sulfatebusiness.industryAndrostenedioneObstetrics and GynecologyDehydroepiandrosteroneAndrogenPolycystic ovaryAndrogen secretionmedicine.anatomical_structureEndocrinologychemistryCase-Control StudiesFemaleLeuprolidebusinesshormones hormone substitutes and hormone antagonistsPolycystic Ovary SyndromeObstetrics & Gynecology
researchProduct

Refractory Acne and 21-Hydroxylase Deficiency in a Selected Group of Female Patients.

2009

<i>Background:</i> Excessive androgen production, suspected in women when acne is accompanied by hirsutism and menstrual irregularities, may be due to congenital adrenal hyperplasia. This inherited disorder of cortisol biosynthesis is caused in more than 90–95% of all cases by 21-hydroxylase deficiency (21-OHD). The steroid 21-hydroxylase gene <i>(CYP21)</i> has a high degree of variability. <i>Objective:</i> This study was conducted to evaluate <i>CYP21 </i>gene mutations in a selected group of women with papulopustular and comedonal acne refractory to treatment, irregular menses and hirsutism. <i>Methods:</i> 30 out of 61 women e…

Adultmedicine.medical_specialtyAdolescentDrug ResistancePhysiologyDermatologyAdrenocorticotropic hormoneYoung AdultSettore MED/38 - Pediatria Generale E SpecialisticaPapulopustularInternal medicineAcne VulgarismedicineHumansPoint MutationCongenital adrenal hyperplasiaGenetic TestingRefractory acne Excessive androgen production Non-classical 21-hydroxylase deficiency CYP21 gene mutations.AcnehirsutismAdrenal Hyperplasia Congenitalmedicine.diagnostic_testbiologybusiness.industry17-alpha-HydroxyprogesteroneACTH stimulation test21-Hydroxylasemedicine.diseasePolycystic ovaryEndocrinologybiology.proteinFemaleSteroid 21-HydroxylaseHyperandrogenismbusinessPolycystic Ovary Syndrome
researchProduct

Studies on the mechanism of mineralocorticoid-induced blood pressure increase in man.

1979

1. To gain insight into the mechanism of mineralocorticoid-induced blood pressure rise in man we performed haemodynamic studies in six normotensive volunteer subjects before and during administration of the synthetic steroid 9α-fluorocortisol (0·8 mg daily) for a period of 6 weeks. In a further study, performed in seven subjects, plasma noradrenaline concentration and reactivity to exogenous noradrenaline were determined before and during administration of the mineralocorticoid. 2. Within the first week of steroid administration an increase in mean arterial blood pressure could be demonstrated, which was due to an increase in cardiac output. After the sixth week the elevated blood pressure …

Adultmedicine.medical_specialtyCardiac outputSympathetic Nervous SystemEpinephrinemedicine.drug_classmedicine.medical_treatmentHemodynamicsBlood PressureSteroidNorepinephrineHeart RateInternal medicineReninmedicineHumansCardiac OutputVolunteerChemistryAngiotensin IIGeneral MedicineEndocrinologyBlood pressurePressor responseMineralocorticoidFludrocortisoneBlood pressure increaseClinical science (London, England : 1979)
researchProduct

Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.

1991

Hirsutism in women is often explained on the basis of abnormal peripheral androgen metabolism. To determine whether serum markers of ovarian, adrenal, or peripheral androgen production may be helpful determinants in the treatment of hirsutism and to compare the efficacy of treatment with dexamethasone or spironolactone, 20 hyperandrogenic hirsute patients were treated for up to 2 years. Eleven women who were selected on the basis of sensitivity to dexamethasone were treated with a daily dose of 0.37 mg dexamethasone and had androgen levels suppressed into the normal range. Although significant (P less than .05), Ferriman-Gallwey scores decreased only by 20%: 14.2 +/- 0.5 to 11.4 +/- 0.6. Ni…

Adultmedicine.medical_specialtyHirsutismAdolescentmedicine.drug_classmedicine.medical_treatmentSpironolactoneAndrogen suppressionAntiandrogenAndrosteroneDexamethasonechemistry.chemical_compoundInternal medicinemedicineHumansTestosteronehirsutismDexamethasoneChemotherapybusiness.industryDehydroepiandrosterone SulfateAndrostenedioneObstetrics and GynecologyAndrogen AntagonistsDihydrotestosteroneGeneral MedicineDehydroepiandrosteroneAndrogenmedicine.diseaseAndrostane-317-diolDrug CombinationsEndocrinologychemistrySpironolactoneAndrogensCorticosteroidFemalebusinessmedicine.drugObstetrics and gynecology
researchProduct

Beclomethasone dipropionate hydrofluoroalkane for the treatment of allergic rhinitis

2016

Allergic rhinitis (AR) is a common respiratory disease, and its prevalence is increasing all over the world, both in adults and in children. Patients experience symptoms that may negatively impact on physical, social and psychological well-being. Hence, if left untreated, allergic rhinitis may significantly affect quality of life. Under current guidelines, intranasal corticosteroids are considered the most effective drugs and they are recommended as first-line therapy. Among the several corticosteroid intranasal sprays available, beclomethasone dipropionate is one of the most prescribed. Recently, new intranasal hydrofluoroalkane-propelled formulations with little or no impact on the ozone …

Adultmedicine.medical_specialtyHydrocarbons Fluorinatedintranasal corticosteroidmedicine.drug_classmedicine.medical_treatmentImmunologynasal sprayAnti-asthmatic AgentMedication Adherence03 medical and health sciencesnasal aerosol0302 clinical medicineQuality of lifeNasal AerosolmedicineAnimalsHumansImmunology and AllergyAnti-Asthmatic AgentsChild030223 otorhinolaryngologyintranasal corticosteroidsAsthmaallergic rhinitisbusiness.industryRespiratory diseaseBeclomethasoneNasal Spraysasthmamedicine.diseaseRhinitis AllergicDermatologyBeclomethasone dipropionate hydrofluoroalkaneAerosol Propellants030228 respiratory systemNasal sprayinflammationQuality of LifeCorticosteroidNasal administrationbusinessallergic rhiniti
researchProduct

Corticobulbar tract involvement in amyotrophic lateral sclerosis. A transcranial magnetic stimulation study

1998

We investigated corticobulbar tract function by recording from the tongue and orofacial muscles and using transcranial magnetic stimulation (TMS) in 30 patients with amyotrophic lateral sclerosis (ALS) in order to improve the diagnostic yield in the detection of subclinical upper motor neuron (UMN) dysfunction. A UMN lesion was assumed when the peripheral conduction time and amplitude of the M-wave were within normal range and either the response to cortical stimulation was absent, or the central conduction time was delayed (> mean + 2.5 SD). Only two patients showed clinical evidence of UMN involvement in the cranial nerves, while TMS demonstrated corticobulbar tract dysfunction in the oro…

Adultmedicine.medical_treatmentPyramidal TractsFacial MusclesCentral nervous system diseaseTongueTonguePhysical StimulationmedicineHumansAmyotrophic lateral sclerosisAgedSubclinical infectionMouthbusiness.industryUpper motor neuronAmyotrophic Lateral SclerosisCranial nervesAnatomyMiddle Agedmedicine.diseaseTranscranial Magnetic StimulationTranscranial magnetic stimulationmedicine.anatomical_structureCorticobulbar tractNeurology (clinical)businessBrain
researchProduct

Morphea after silicone gel breast implantation for cosmetic reasons in an HLA-B8,DR3-positive woman

1997

We describe an HLA-B8, DR3-positive patient with localized morphea after silicone gel breast implantation for cosmetic reasons. We believe that this case suggests that a genetic background, i.e. HLA-B8, DR3 haplotype, is involved in the autoimmune response to silicone.

Adultmusculoskeletal diseasesmedicine.medical_specialtyBreast implantationBreast ImplantsMammaplastyImmunologyMammary glandCD4-CD8 RatioSiliconesHLA-B8 AntigenScleroderma Localizedchemistry.chemical_compoundHLA-DR3 AntigenSiliconeLocalized morpheamedicineHumansImmunology and AllergySurgery Plasticskin and connective tissue diseasesGlucocorticoidsbusiness.industrytechnology industry and agricultureGeneral Medicinemedicine.diseaseConnective tissue diseaseSurgeryPlastic surgerymedicine.anatomical_structurechemistryImmunologyPrednisoneFemalebusinessMorpheaCircumscribed scleroderma
researchProduct

Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission.…

2019

Abstract To assess the effectiveness of the treatment with high dosage of corticosteroids (CCSs), as first-line therapy, in inducing remission in naïve Adult-onset Still's disease (AOSD) patients compared with low dosage of CCSs, after 6 months. To further evaluate the rate of patients maintaining the remission and the rate of CCSs discontinuation, after additional 12 months of follow-up. A retrospective evaluation of patients prospectively followed was designed to compare the rate of clinical remission in naïve AOSD patients treated with high dosages of CCSs (0.8–1 mg/kg/day of prednisone-equivalent) or low dosage of CCSs (0.2–0.3 mg/kg/day of prednisone-equivalent), after 6 months. An add…

Adult-OnsetMalePediatricsAdult-onset Still's diseaseDiseaseAdrenal Cortex Hormonecorticosteroids0302 clinical medicinemonocyclic patternAdrenal Cortex HormonesRetrospective StudieMedicine030212 general & internal medicineProspective StudiesProspective cohort studyRemission InductionDisease ManagementGeneral MedicineMiddle AgedTreatment OutcomeHigh dosage030220 oncology & carcinogenesisFemaleDrugStill's Disease Adult-OnsetResearch ArticleHumanAdultcorticosteroidmedicine.medical_specialtyLow dosageObservational StudyAdult-onset Still's diseaseFollow-Up StudieDose-Response Relationship03 medical and health sciencesremissionAdult-onset Still's disease; corticosteroids; first-line therapy; monocyclic pattern; remission; Adrenal Cortex Hormones; Adult; Disease Management; Dose-Response Relationship Drug; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Remission Induction; Retrospective Studies; Still's Disease Adult-Onset; Treatment Outcomefirst-line therapyHumansRetrospective StudiesDose-Response Relationship Drugbusiness.industry6900Retrospective cohort studyStill's DiseaseFirst line treatmentSettore MED/16 - ReumatologiaProspective StudieMethotrexateObservational studybusinessFollow-Up Studies
researchProduct

Morphological and biochemical effects of glucocorticoids in chick embryo hepatocytes during development

1988

Abstract The administration in ovo of hydrocortisone-21-phosphate caused, in chick embryo liver, a reduction of the number of hepatocytes which can be isolated from 1 mg dry weight of liver and a marked increase of their size. Moreover, the treatment diminished the incorporation of thymidine into acid-insoluble fraction in these cells whilst it augmented the content of protein, RNA, DNA and the level of thymidine kinase/cell. These effects were highest at 8–10 days, then declined with the age, disappearing after 18th day of incubation. Similar effects were obtained by injecting other glucocorticoids or ACTH. Combined treatment with metopirone abolished the effects found with ACTH, but did n…

Agingmedicine.medical_specialtyHydrocortisoneChick EmbryoBiologyPeptide hormoneIn ovoThymidine Kinasebiochemical effectschemistry.chemical_compoundAdrenocorticotropic HormoneInternal medicinemedicineAnimalsGlucocorticoidsIncubationEmbryogenesisEmbryoMetyraponeEndocrinologyLiverchemistryThymidine kinaseThymidineGlucocorticoidDevelopmental Biologymedicine.drug
researchProduct